Manager TitleAgeSince
Chief Executive Officer 86 01/09/2013
Director of Finance/CFO 55 01/10/2012
Director TitleAgeSince
Chairman 54 12/08/2021
Director/Board Member 45 -
Director/Board Member 54 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-38.68% - - 1L
-0.78%-1.42%+2.96%+21.65% 5.05TCr
-6.00%-0.75%+447.48%+535.14% 4.46TCr
-0.24%+0.74%+37.18%+16.26% 4.31TCr
-1.55%-2.07%+19.83%+71.70% 4.17TCr
-0.31%-0.83%+19.47%+48.24% 3.32TCr
-1.79%-3.24%+26.32%+125.06% 1.68TCr
-0.58%-2.12% - - 1.63TCr
-0.88%-0.66%+11.63%+27.62% 1.46TCr
-1.66%-1.25%+78.49%+42.97% 1.39TCr
Average -1.38%-1.06%+80.42%+111.08% 3.05TCr
Weighted average by Cap. -1.70%-1.06%+96.28%+129.03%

Financials

2020 2021
Net sales 15.02L 17.4L 14.08L 12.86L 24.19L 17Cr 24.3L 1.67Cr 65.17L 8.4Cr 65.3L 63.88L 28Cr 10.77L 12.47L 10.1L 9L 17.34L 12Cr 17.42L 1.2Cr 46.73L 6.02Cr 46.82L 45.8L 20Cr
Net income 1.47Cr 1.71Cr 1.38Cr 1.26Cr 2.37Cr 162.87Cr 2.39Cr 16Cr 6.4Cr 82Cr 6.41Cr 6.27Cr 273.48Cr -1.06Cr -1.22Cr -99.12L -90.49L -1.7Cr -116.79Cr -1.71Cr -12Cr -4.59Cr -59Cr -4.6Cr -4.5Cr -196.1Cr
Net Debt - -
Logo MagForce AG
Magforce AG is a Germany-based company engaged in the provision of nanotechnology solutions for health sector. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The Company's range of treatment products includes NanoTherm Therapie for treating tumors locally; NanoTherm, a fluid containing ferrous oxide molecules that penetrate deeply into the tumor tissues and reacting to the presence of a magnetic field; NanoActivator, which are iron oxide nanoparticles for tumors in all areas of the body, and NanoPlan, a software platform that facilitates therapy planning and adjusts proper temperatures for the treatment and and the necessary magnetic field strength. As of December 31, 2011, Nanostart AG held a 49.6%-stake in the Company.
Employees
33